Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Warts 1

Interventions

resiquimod 6VP-102 2N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2Cantharidin 22-Propanol 2methyl 5-aminolevulinate 1ammonium trichloro(dioxoethylene-O,O'-)tellurate 1Sugars 1Photochemotherapy 1Nitric Oxide 1Maltose 1Interferon-alpha 1Imiquimod 1Exercise 1Equipment and Supplies 1Cryotherapy 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Warts × Nitric Oxide × Clear all
NCT05877313 2024-04-17

Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)

Sanotize Research and Development corp.

Phase 2 Completed
20 enrolled

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡